Meeting
2013 ASCO Annual Meeting
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial.
Authors
Hans-Joachim Schmoll
Martin Luther University Halle-Wittenberg, Halle, Germany
Hans-Joachim Schmoll , Karin Haustermans , Timothy Jay Price , Bernard Nordlinger , Ralf Hofheinz , Jean-Francois Daisne , Jozef Janssens , Baruch Brenner , Peter Schmidt , Hans Reinel , Stephan Hollerbach , Karel Caca , Florian W.B. Fauth , Carla Hannig , John Raymond Zalcberg , Niall C. Tebbutt , Murielle E. Mauer , Carlo G. M. Messina , Manfred P. Lutz , Eric Van Cutsem
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Clinical Trial Registration Number
NCT00766155
Citation
J Clin Oncol 31, 2013 (suppl; abstr 3531)
DOI
10.1200/jco.2013.31.15_suppl.3531
Abstract #
3531
Poster Bd #
23
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Ensemble study: A multicenter, randomized, phase III trial to test the superiority of consolidation irinotecan, capecitabine and oxaliplatin vs capecitabine and oxaliplatin following short course radiotherapy as total neoadjuvant therapy in patients with locally advanced rectal cancer.
First Author: Jun Watanabe
Poster
2021 ASCO Annual Meeting
A multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): The final reports.
First Author: Jing Jin
Poster
2021 ASCO Annual Meeting
Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.
First Author: Ji Zhu
Poster
2020 ASCO Virtual Scientific Program
Is there a benefit of oxaliplatin in neoadjuvant treatment of locally advanced rectal cancer? An updated meta-analysis.
First Author: Gaetan Des Guetz